Thyroid Cancer pp 865-869 | Cite as

Cytology and Pathology of Medullary Thyroid Cancer

Chapter

Abstract

First defined in the 1950s, medullary carcinoma of the thyroid is a tumor derived from the non-follicular C cell in the gland. The origin of this tumor was first proposed in the mid-1960s by ED Williams, who postulated (based on a few cases) that this unusual thyroid tumor, medullary carcinoma, might indeed be derived from non-follicular thyroid cells, i.e., the C cells, and that a new hormone might be produced by these cells in the thyroid. If so, he theorized that medullary carcinoma could produce calcitonin, and this could become a diagnostic and prognostic marker for this neoplasm. Most importantly the precursor lesion known as C-cell hyperplasia was identified.

Keywords

Cytology Pathology Medullary thyroid cancer 

References

  1. 1.
    Horn RC. Carcinoma of the thyroid: description of a distinctive morphologic variant and report of seven cases. Cancer. 1951;4:697–707.CrossRefGoogle Scholar
  2. 2.
    Hazard JB, Hawk WA, Crile G. Medullary (solid) carcinoma of the thyroid. A clinicopathologic entity. J Clin Endocrinol Metab. 1959;19:152–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Williams ED. Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol. 1966;19:114–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Wolfe HJ, Melvin KE, Cervi-Skinner SJ, Saadi AA, Juliar JF, Jackson CE, Tashjian Jr AH. C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med. 1973;289:437–41.CrossRefPubMedGoogle Scholar
  5. 5.
    Sipple JH. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med. 1961;31:163–6.CrossRefGoogle Scholar
  6. 6.
    Skinner MA, Wells Jr SA. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Semin Pediatr Surg. 1997;6:134–40.PubMedGoogle Scholar
  7. 7.
    Mulligan LM, Eng C, Attie T, Lyonnet S, Marsh DJ, Hyland VJ, Robinson BG, Frilling A, Verellen-Dumoulin C, Safar A, et al. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet. 1994;3:2163–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Massoll N, Mazzaferri EL. Diagnosis and management of medullary thyroid carcinoma. Clin Lab Med. 2004;24:49–83.CrossRefPubMedGoogle Scholar
  9. 9.
    Asa SL. How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape. Mod Pathol. 2001;14:246–53.CrossRefPubMedGoogle Scholar
  10. 10.
    Wolfe HJ, Delellis RA. Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab. 1981;10:351–65.CrossRefPubMedGoogle Scholar
  11. 11.
    DeLellis RA, Nunnemacher G, Bitman WR, Gagel RF, Tashjian Jr AH, Blount M, Wolfe HJ. C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis. Lab Invest. 1979;40:140–54.PubMedGoogle Scholar
  12. 12.
    Albores-Saavedra J, LiVolsi VA, Williams ED. Medullary carcinoma. Semin Diagn Pathol. 1985;2:137–46.PubMedGoogle Scholar
  13. 13.
    Holm R, Sobrinho Simoes M, Nesland JM, Gould VE, Johannessen JV. Medullary carcinoma of the thyroid gland: an immunocytochemical study. Ultrastruct Pathol. 1985;8:25.CrossRefPubMedGoogle Scholar
  14. 14.
    Ho C, Lin JD, Huang YY, Huang HS, Huang BY, Hsueh C. Clinical experience of medullary thyroid carcinoma in Chang Gung Memorial Hospital. Chang Keng I Hsueh. 1996;19:142–8.PubMedGoogle Scholar
  15. 15.
    Forrest CH, Frost FA, de Boer WB, Spagnolo DV, Whitaker D, Sterrett BF. Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer. 1998;84:295–302.CrossRefPubMedGoogle Scholar
  16. 16.
    Kaushal S, Iyer VK, Mathur SR, Ray R. Fine needle aspiration cytology of medullary carcinoma of the thyroid with a focus on rare variants: a review of 78 cases. Cytopathology. 2010.Google Scholar
  17. 17.
    Mendelsohn G, Baylin SB, Bigner SH, Wells Jr SA, Eggleston JC. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol. 1980;4:333–41.CrossRefPubMedGoogle Scholar
  18. 18.
    Yerly S, Triponez F, Meyer P, Kumar N, Bongiovanni M. Medullary thyroid carcinoma, small cell variant, as a diagnostic challenge on fine needle aspiration: a case report. Acta Cytol. 2010;54:911–7.PubMedGoogle Scholar
  19. 19.
    Harach HR, Bergholm U. Medullary (C cell) carcinoma of the thyroid with features of follicular oxyphilic cell tumours. Histopathology. 1988;13:645–56.CrossRefPubMedGoogle Scholar
  20. 20.
    Dedivitis RA, Di Giovanni JH, Silva GF, Marinho LC, Guimaraes AV. Oncocytic variant of medullary thyroid carcinoma: case report. Arq Bras Endocrinol Metabol. 2004;48:315–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Tranchida P, Estigarribia J, Sethi S, Giorgadze T. Cytologic diagnosis of recurrent medullary thyroid carcinoma with oncocytic change twenty-one years post-thyroidectomy: case report and review of the literature. Diagn Cytopathol. 2011;39:641–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Zaatari GS, Saigo PE, Huvos AG. Mucin production in medullary carcinoma of the thyroid. Arch Pathol Lab Med. 1983;107:70–4.PubMedGoogle Scholar
  23. 23.
    Singh K, Sharma MC, Jain D, Kumar R. Melanotic medullary carcinoma of thyroid – report of a rare case with brief review of literature. Diagn Pathol. 2008;3:2.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Ben Romdhane K, Khattech R, Ben Othman M, Gamoudi A, Ammar A, Cammoun M. Melanin production in medullary thyroid carcinoma. Histopathology. 1995;27:569–71.CrossRefPubMedGoogle Scholar
  25. 25.
    Khurana R, Agarwal A, Bajpai VK, Verma N, Sharma AK, Gupta RP, Madhusudan KP. Unraveling the amyloid associated with human medullary thyroid carcinoma. Endocrinology. 2004;145:5465–70.CrossRefPubMedGoogle Scholar
  26. 26.
    Us-Krasovec M, Auersperg M, Bergant D, Golouh R, Kloboves-Prevodnik V. Medullary carcinoma of the thyroid glad: diagnostic cytopathological characteristics. Pathologica. 1998;90:5–13.PubMedGoogle Scholar
  27. 27.
    Samaan NA, Schultz PN, Hickey RC. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab. 1988;67:801–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Schroder S, Bocker W, Baisch H, Burk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Kloppel G. Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer. 1988;61:806–16.CrossRefPubMedGoogle Scholar
  29. 29.
    Bergholm U, Adami HO, Auer G, Bergstrom R, Backdahl M, Grimelius L, Hansson G, Ljungberg O, Wilander E. Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. The Swedish MTC Study Group. Cancer. 1989;64:135–42.CrossRefPubMedGoogle Scholar
  30. 30.
    Pastolero GC, Coire CI, Asa SL. Concurrent medullary and papillary carcinomas of thyroid with lymph node metastases. A collision phenomenon. Am J Surg Pathol. 1996;20:245–50.CrossRefPubMedGoogle Scholar
  31. 31.
    Oertel YC, Oertel JE. Diagnosis of malignant epithelial thyroid lesions: fine needle aspiration and histopathologic correlation. Ann Diagn Pathol. 1998;2:377–400.CrossRefPubMedGoogle Scholar
  32. 32.
    Zeppa P, Benincasa G, Lucariello A, Palombini L. Association of different pathologic processes of the thyroid gland in fine needle aspiration samples. Acta Cytol. 2001;45:347–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Costanzo M, Marziani A, Papa V, Arcerito MC, Cannizzaro MA. Simultaneous medullary carcinoma and differentiated thyroid cancer. Case report. Ann Ital Chir. 2010;81:357–60.PubMedGoogle Scholar
  34. 34.
    Randolph GW. Medullary carcinoma of the thyroid: subtypes and current management. Compr Ther. 1996;22:203–10.PubMedGoogle Scholar
  35. 35.
    Heptulla RA, Schwartz RP, Bale AE, Flynn S, Genel M. Familial medullary thyroid carcinoma: presymptomatic diagnosis and management in children. J Pediatr. 1999;135:327–31.CrossRefPubMedGoogle Scholar
  36. 36.
    Wu LS, Roman SA, Sosa JA. Medullary thyroid cancer: an update of new guidelines and recent developments. Curr Opin Oncol. 2011;23:22–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Albores-Saavedra JA, Krueger JE. C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol. 2001;12:365–77.CrossRefPubMedGoogle Scholar
  38. 38.
    Mizukami Y, Kurumaya H, Nonomura A, Michigishi T, Terahata S, Noguchi M, Hashimoto T, Matsubara F. Sporadic medullary microcarcinoma of the thyroid. Histopathology. 1992;21:375–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ. Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. Arch Pathol Lab Med. 2008;132:1767–73.PubMedGoogle Scholar
  40. 40.
    Kazaure HS, Roman SA, Sosa JA. Medullary thyroid microcarcinoma: a population-level analysis of 310 patients. Cancer. 2011.Google Scholar
  41. 41.
    Collins BT, Cramer HM, Tabatowski K, Hearn S, Raminhos A, Lampe H. Fine needle aspiration of medullary carcinoma of the thyroid. Cytomorphology, immunocytochemistry and electron microscopy. Acta Cytol. 1995;39:920–30.PubMedGoogle Scholar
  42. 42.
    Papaparaskeva K, Nagel H, Droese M. Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagn Cytopathol. 2000;22:351–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Boyd LA, Earnhardt RC, Dunn JT, Frierson HF, Hanks JB. Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules. J Am Coll Surg. 1998;187:494–502.CrossRefPubMedGoogle Scholar
  44. 44.
    Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tuzun M, Yetkin E, Tuncyurek M, Kabalak T. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid. 1999;9:579–82.CrossRefPubMedGoogle Scholar
  45. 45.
    Trimboli P, Rossi F, Baldelli R, Laurenti O, Nigri G, Ventura C, Appetecchia M, Attanasio D, Romanelli F, Guidobaldi L, Guarino M, Crescenzi A, Valabrega S. Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer. Diagn Cytopathol. 2011.Google Scholar
  46. 46.
    Parker LN, Kollin J, Wu SY, Rypins EB, Juler GL. Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern. Arch Intern Med. 1985;145:1507–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Albores-Saavedra J, Gorraez de la Mora T, de la Torre-Rendon F, Gould E. Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma. Hum Pathol. 1990;21:1151–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Sobrinho-Simoes M. Mixed medullary and follicular carcinoma of the thyroid. Histopathology. 1993;23:287–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineUniversity of Pennsylvania Medical Center, Perelman School of MedicinePhiladelphiaUSA

Personalised recommendations